390
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone

, , , &
Pages 40-43 | Received 27 Sep 2009, Accepted 22 Nov 2009, Published online: 11 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hung-Jen Shih, Pei-Shan Tsai, Yu-Ching Wen, Ming-Chang Kao, Yen-Chun Fan & Chun-Jen Huang. (2020) Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. The Aging Male 23:5, pages 354-361.
Read now
Niki Katsiki, Genovefa Kolovou, Pablo Perez-Martinez & Dimitri P. Mikhailidis. (2018) Dyslipidaemia in the elderly: to treat or not to treat?. Expert Review of Clinical Pharmacology 11:3, pages 259-278.
Read now

Articles from other publishers (5)

Matthew Alberto, Arthur Yim, Nathan Lawrentschuk & Damien Bolton. (2023) Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer. Cancers 15:2, pages 341.
Crossref
Neeja Patel, Nikita Mittal, Parnia Abolhassan Choubdar & Pam R. Taub. (2022) Lipoprotein(a)—When to Screen and How to Treat. Current Cardiovascular Risk Reports 16:10, pages 111-120.
Crossref
Adrian Rosada, Ursula Kassner, Felix Weidemann, Maximilian König, Nikolaus Buchmann, Elisabeth Steinhagen-Thiessen & Dominik Spira. (2020) Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study. Lipids in Health and Disease 19:1.
Crossref
Heitor O. Santos, Richard Kones, Umme Rumana, Conrad P. Earnest, Luiz F.M. Izidoro & Rodrigo C.O. Macedo. (2019) Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies. Clinical Therapeutics 41:9, pages 1780-1797.
Crossref
Akl C. Fahed, Joanna M. Gholmieh & Sami T. Azar. (2012) Connecting the Lines between Hypogonadism and Atherosclerosis. International Journal of Endocrinology 2012, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.